Testimony by Managing Director Phillip Johnson was cited by the Court in the recent certification of a class of those who purchased CRTs. Dr. Johnson’s testimony on classwide impact and damages resulting from collusion in the CRT industry was cited by the Court, which stated: “the Court agrees with DPPs that Johnson’s expert analysis is capable of demonstrating antitrust impact and damages on a classwide basis.
Read the Law360 coverage here >.
Read the class certification order here >.
Share this article: